Literature DB >> 14605312

Risks related to catheter locking solutions containing concentrated citrate.

Hans-Dietrich Polaschegg, Klaus Sodemann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14605312     DOI： 10.1093/ndt/gfg481

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  13 in total

1.  Stability of trisodium citrate and gentamicin solution for catheter locks after storage in plastic syringes at room temperature.

Authors:  Dennis Cote; Charmaine E Lok; Marisa Battistella; Lavern Vercaigne
Journal:  Can J Hosp Pharm       Date:  2010-07

2.  Antimicrobial Efficacy and Safety of a Novel Gas Plasma-Activated Catheter Lock Solution.

Authors:  Sudhir Bhatt; Poonam Mehta; Chen Chen; Dayle A Daines; Leonard A Mermel; Hai-Lan Chen; Michael G Kong
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

3.  Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

Review 4.  Prevention of catheter-related bloodstream infection in patients on hemodialysis.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

5.  Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS).

Authors:  Jennifer M Macrae; Ivana Dojcinovic; Ognjenka Djurdjev; Beverly Jung; Steven Shalansky; Adeera Levin; Mercedeh Kiaii
Journal:  Clin J Am Soc Nephrol       Date:  2008-03       Impact factor: 8.237

6.  Glyceryl trinitrate complements citrate and ethanol in a novel antimicrobial catheter lock solution to eradicate biofilm organisms.

Authors:  Joel Rosenblatt; Ruth Reitzel; Tanya Dvorak; Ying Jiang; Ray Y Hachem; Issam I Raad
Journal:  Antimicrob Agents Chemother       Date:  2013-05-13       Impact factor: 5.191

7.  Cluster-Randomized Trial of Devices to Prevent Catheter-Related Bloodstream Infection.

Authors:  Steven M Brunelli; David B Van Wyck; Levi Njord; Robert J Ziebol; Laurie E Lynch; Douglas P Killion
Journal:  J Am Soc Nephrol       Date:  2018-02-22       Impact factor: 10.121

8.  Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.

Authors:  Rémi Bruyère; Agnès Soudry-Faure; Gilles Capellier; Christine Binquet; Abdelouaid Nadji; Stephane Torner; Gilles Blasco; Maria Yannaraki; Saber Davide Barbar; Jean-Pierre Quenot
Journal:  Trials       Date:  2014-11-19       Impact factor: 2.279

9.  Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens).

Authors:  Janusz Steczko; Stephen R Ash; David E Nivens; Lloyd Brewer; Roland K Winger
Journal:  Nephrol Dial Transplant       Date:  2009-01-30       Impact factor: 5.992

Review 10.  Bench-to-bedside review: Challenges of diagnosis, care and prevention of central catheter-related bloodstream infections in children.

Authors:  Susanne Janum; Walter Zingg; Volker Classen; Arash Afshari
Journal:  Crit Care       Date:  2013-08-28       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.